Cis-Clopidogrel-MP derivative

Cis-Clopidogrel-MP derivative (Clopidogrel-MP-AM) is a 3’-methoxyacetophenone derivative of Clopidogrel active metabolite[1]. Clopidogrel is an orally active platelet inhibitor that targets P2Y12 receptor[2].

Product Specifications

CAS Number

[1122047-98-6]

Product Name Alternative

Clopidogrel-MP-AM

UNSPSC

12352005

Target

Drug Metabolite

Type

Reference compound

Related Pathways

Metabolic Enzyme/Protease

Field of Research

Others

Assay Protocol

https://www.medchemexpress.com/cis-clopidogrel-mp-derivative.html

Purity

97.79

Solubility

DMSO : 2.5 mg/mL (ultrasonic; warming)

Smiles

COC1=CC=CC(C(CSC2CCN([C@H](C(OC)=O)C3=C(Cl)C=CC=C3)C/C2=C/C(O)=O)=O)=C1

Molecular Formula

C25H26ClNO6S

Molecular Weight

504.00

References & Citations

[1]Makoto Takahashi, et al. Quantitative determination of clopidogrel active metabolite in human plasma by LC-MS/MS. harm Biomed Anal. 2008 Dec 1;48 (4) :1219-24.|[2]Zongyu Zheng, et al. Clopidogrel Reduces Fibronectin Accumulation and Improves Diabetes-Induced Renal Fibrosis. Int J Biol Sci. 2019 Jan.